C12N 2760/00071
Demonstrated in vivo effect
C12N2760/00071 (Demonstrated in vivo effect) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 4
- Inventors
- 15
- Latest grant
- 25 May 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
By publication year.
Recent patents
- Compositions and Methods for Generating an Immune Response to LASV4 Jun 2020US 2020/0171141 A1GeoVax, Inc.
- Lipids and Lipid Compositions for the Delivery of Active Agents28 Nov 2019US 2019/0358170 A1Novartis AG
- Gene vaccine for preventing and treating severe fever with thrombocytopenia syndrome1 Aug 2019US 2019/0231862 A1Slbigen Inc.
- New adjuvant and vaccine composition containing the same1 Nov 2018US 2018/0311340 A1Cadila Healthcare Limited
- Lipids and Lipid Compositions for the Delivery of Active Agents3 Nov 2016US 2016/0317458 A1Novartis AG
Most cited
By later US patents